- Home
- » Tags
- » Pharmacophore
Top View
- Pharmacophore Modeling, Quantitative Structure–Activity
- Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro
- Part I Introduction
- Structure-Based Pharmacophore Modeling, Virtual Screening
- Pharmacophore Approach in Drug Discovery
- Design and Screening of "Pharmacophore" Motifs NIKOLAI F
- Week 7 Chapter 11
- QPHAR: Quantitative Pharmacophore Activity Relationship: Method and Validation Stefan M
- A Molecular Image-Based Novel Quantitative Structure-Activity Relationship Approach, Deepsnap-Deep Learning and Machine Learning
- QSAR and Its Role in Target-Ligand Interaction
- QSAR and Pharmacophore Modeling of Nitrogen Heterocycles As Potent Human N-Myristoyltransferase (Hs-NMT) Inhibitors
- Ligand-Based and Structure-Based Virtual Screening
- The Use of a Quantitative Structure- Activity Relationship (QSAR) Model to Predict GABA-A Receptor Binding of Newly Emerging Benzodiazepines
- Designing Ligands Using Molecular Dynamics Simulations with Water Received: 25 January 2018 Sang Won Jung1,5, Minsup Kim1, Steven Ramsey2,4, Tom Kurtzman2,3,4 & Art E
- Palleros – Medicinal Chemistry I
- Lecture on Pharmacophores
- Hybrid Pharmacophore Approach As a Novel Strategy to Identify Anti
- Pharmacophores and Their Applications
- The Origin of FDA Approved Natural Product New Chemical Entities
- 3D Pharmacophores As Tools for Activity Profiling
- A Review on Applications of Computational Methods in Drug Screening and Design
- What Is the Dopaminergic Pharmacophore in Ergot Alkaloids?
- Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
- Generation of Pharmacophores and Classification of Drugs Using Protein-Ligand Complexes
- 3D Pharmacophore-Based Discovery of Novel KV10.1 Inhibitors with Antiproliferative Activity
- The Pharmaceutical Industry in 2020. an Analysis of FDA Drug Approvals from the Perspective of Molecules
- Current Computational Methods for Predicting Protein Interactions of Natural Products ⇑ Aurélien F.A
- Molecular Docking, Pharmacophore Modelling, and Adme-Toxicity Prediction of Curcumin Analog Compounds As Inflammatory Inhibitor on Rheumatoid Arthritis
- Strategies and Challenges Involved in the Discovery of New Chemical Entities During Early-Stage Tuberculosis Drug Discovery
- Identifying the Macromolecular Targets of De Novo-Designed Chemical Entities Through Self-Organizing Map Consensus
- Multifunctionality of Drug's Pharmacophores Within an Organism